Treatment of pulmonary thromboembolism

Internal Medicine

Volumn 38, Issue 8, 1999, Pages 620-625

  Goldhaber, Samuel Z ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Low molecular weight heparin; Pulmonary embolism; Thrombolysis; Thrombophlebitis

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ARTERIAL PRESSURE; BLOOD CLOT LYSIS; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; EMBOLECTOMY; HEART RIGHT VENTRICLE PERFORMANCE; HUMAN; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MORTALITY; PARTIAL THROMBOPLASTIN TIME; REVIEW; RISK ASSESSMENT;

EID: 0032790529     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.38.620     Document Type: Review

References (42)

1. Elliott CG. Pulmonary physiology during pulmonary embolism. Chest 101: 163S-171S, 1992.
2. Goldhaber SZ, Visani L, De Rosa M for ICOPER. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999: April 24, 1999.
3. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 326: 1240-1245, 1992.
4. Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, Johnsson H, Jorfeldt L. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 134: 479-487, 1997.
5. Kasper W, Konstantinides S, Geibel A, Tiode N, Krause T, Just H. Prognostic significance of right ventricular afterload stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 77: 346-349, 1997.
6. Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol 30: 1165-1171, 1997.
7. Hull RD, Hirsh J, Carter CJ, et al. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med 98: 891-899, 1983.
8. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 263: 2753-2759, 1990.
9. Gottschalk A, Sostman HD, Coleman RE, et al. Ventilation-perfusion scintigraphy in the PIOPED study. Part II. Evaluation of the scintigraphic criteria and interpretations. J Nucl Med 34: 1119-1126, 1993.
10. Stein PD, Terrin ML, Gottschalk A, Alavi A, Henry JW. Value of ventilation/perfusion scans versus perfusion scans alone in acute pulmonary embolism. Am J Cardiol 69: 1239-1241, 1992.
11. Bone RC. The low-probability lung scan. A potentially lethal reading. Arch Intern Med 153: 2621-2622, 1993.
12. Hull RD, Raskob GE, Pineo GF, Brant RF. The low-probability lung scan. A need for change in nomenclature. Arch Intern Med 155: 1845-1851, 1995.
13. Remy-Jardin M, Remy J, Deschildre F, et al. Diagnosis of pulmonary embolism with spiral CT: comparison with pulmonary angiography and scintigraphy. Radiology 200: 699-706, 1996.
14. Meaney JF, Weg JG, Chenevert TL, Stafford-Johnson D, Hamilton BH, Prince MR. Diagnosis of pulmonary embolism with magnetic resonance angiography. N Engl J Med 336: 1422-1427, 1997.
15. Jardin F, Dubourg O, Bourdarias JP. Echocardiographic pattern of acute cor pulmonale. Chest 111: 209-217, 1997.
16. McConnell MV, Solomon SD, Rayan ME, Come PC, Goldhaber SZ, Lee RT. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 78: 469-473, 1996.
17. Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary Embolism: One-year follow-up with echocardiography doppler and five-year survival analysis. Circulation 99: 1325-1330, 1999.
18. Stein PD, Athanasoulis C, Alavi A, et al. Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation 85: 462-468, 1992.
19. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Ann Intern Med 119: 874-881, 1993.
20. Toglia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 335: 108-114, 1996.
21. Callander N, Rapaport SI. Trousseau's syndrome. West J Med 158: 364-371, 1993.
22. The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 337: 657-662, 1997.
23. Simonneau G, Sors H, Charbonnier B, et al, and The THESEE Study Group. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. Tinzaparine ou Heparin Standard: Evaluations dans l'Embolie Plumonaire. N Engl J Med 337: 663-669, 1997.
24. Pacouret G, Alison D, Pottier JM, Bertrand P, Charbonnier B. Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis. A prospective study. Arch Intern Med 157: 305-308, 1997.
25. Decousus H, Leizorovicz A, Parent F, et al, and Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group [see comments]. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 338: 409-415, 1998.
26. Harrison L, Johnston M, Massicotte MP, Crowther M, Moffat K, Hirsh J. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med 126: 133-136, 1997.
27. Crowther MA, Ginsberg JB, Kearon C, et al. A randomized trial comparing 5-mg and 10-mg warfarin loading doses. Arch Intern Med 159: 46-48, 1999.
28. Schulman S, Rhedin AS, Lindmarker P, et al, and Duration of Anticoagulation Trial Study Group. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 332: 1661-1665, 1995.
29. Schulman S, Granqvist S, Holmstrom M, et al, and The Duration of Anticoagulation Trial Study Group. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 336: 393-398, 1997.
30. Ridker PM. Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial. Vasc Med 3: 67-73, 1998.
31. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 340: 901-907, 1999.
32. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341: 507-511, 1993.
33. Konstantinides S, Geibel A, Olschewski M, et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulaiton 96: 882-888, 1997.
34. Mikkola KM, Patel SR, Parker JA, Grodstein F, Goldhaber SZ. Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. Am Heart J 134: 69-72, 1997.
35. Greenfield LJ, Proctor MC, Williams DM, Wakefield TW. Long-term experience with transvenous catheter pulmonary embolectomy. J Vasc Surg 18: 450-7; discussi, 1993.
36. Gulba DC, Schmid C, Borst HG, Lichtlen P, Dietz R, Luft FC. Medical compared with surgical treatment for massive pulmonary embolism. Lancet 343: 576-577, 1994.
37. Goldhaber SZ. Integration of catheter thrombectomy into our armamentarium to treat acute pulmonary embolism. Chest 114: 1237-1238, 1998.
38. Nass N, McConnell MV, Goldhaber SZ, Chyu S, Solomon SD. Recovery of regional right ventricular function after thrombolysis for pulmonary embolism. Am J Cardiol 83: 804-6, A10, 1999.
39. Weitz JI. Low-molecular-weight heparins. N Engl J Med 337: 688-698, 1997 (published erratum appears in N Engl J Med 337: 1567. 1997).
40. Simonneau G, Sors H, Charbonnier B, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 337: 663-669, 1997.
41. Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 337: 657-662, 1997.
42. Abildgaard U, Davidson BL, Eldor A, et al. A comparison of subcutaneous enoxaparin given once or twice daily and intravenous unfractionated heparin in the treatment of venous thromboembolic disease. The Enoxaparin Clinical Trial Group (personal communication).